49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Sharma S, Arunachalam PS, Menon M, Ragupathy V, Satya RV, Jebaraj J, Ganeshappa Aralaguppe S, Rao C, Pal S, Saravanan S, Murugavel KG, Balakrishnan P, Solomon S, Hewlett I, Ranga U. PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C. The Journal of Biological Chemistry. PMID 29773649 DOI: 10.1074/jbc.M117.815829  0.48
2017 Sharma S, Aralaguppe SG, Abrahams MR, Williamson C, Gray C, Balakrishnan P, Saravanan S, Murugavel KG, Solomon S, Ranga U. The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa. Bmc Infectious Diseases. 17: 95. PMID 28118816 DOI: 10.1186/s12879-017-2184-4  0.44
2016 Negi N, Vajpayee M, Singh R, Sharma A, Murugavel KG, Ranga U, Thakar M, Sreenivas V, Das BK. Cross-Reactive Potential of HIV-1 Subtype C-Infected Indian Individuals Against Multiple HIV-1 Potential T Cell Epitope Gag Variants. Viral Immunology. PMID 27875663 DOI: 10.1089/vim.2016.0060  0.44
2016 Arunachalam PS, Mishra R, Badarinath K, Selvam D, Payeli SK, Stout RR, Ranga U. Toll-Like Receptor 9 Activation Rescues Impaired Antibody Response in Needle-free Intradermal DNA Vaccination. Scientific Reports. 6: 33564. PMID 27658623 DOI: 10.1038/srep33564  0.36
2016 Verma A, Rajagopalan P, Lotke R, Varghese R, Selvam D, Kundu TK, Ranga U. Functional incompatibility between the generic NF-κB motif and a subtype-specific Sp1III element drives the formation of HIV-1 subtype C viral promoter. Journal of Virology. PMID 27194770 DOI: 10.1128/JVI.00308-16  0.48
2016 Dhanasekaran K, Kumari S, Boopathi R, Shima H, Swaminathan A, Bachu M, Ranga U, Igarashi K, Kundu TK. Multifunctional Human Transcriptional Co-activator Protein PC4 is a Substrate of Aurora Kinases and Activates the Aurora Enzymes. The Febs Journal. PMID 26777301 DOI: 10.1111/febs.13653  0.48
2015 G Aralaguppe SP, Sharma S, Menon M, Prasad VR, Saravanan S, Murugavel KG, Solomon S, Ranga U. The evolving profile of the signature amino acid residues in HIV-1 subtype C Tat. Aids Research and Human Retroviruses. PMID 26678403 DOI: 10.1089/AID.2015.0208  0.48
2015 Kumari S, Das C, Sikder S, Kumar M, Bachu M, Ranga U, Kundu TK. Identification and characterization of nonhistone chromatin proteins: human positive coactivator 4 as a candidate. Methods in Molecular Biology (Clifton, N.J.). 1288: 245-72. PMID 25827884 DOI: 10.1007/978-1-4939-2474-5_14  0.48
2015 Mishra M, Varghese RK, Verma A, Das S, Aguiar RS, Tanuri A, Mahadevan A, Shankar SK, Satishchandra P, Ranga U. Genetic diversity and proviral DNA load in different neural compartments of HIV-1 subtype C infection. Journal of Neurovirology. PMID 25750071 DOI: 10.1007/s13365-015-0328-0  0.48
2015 Ramana LN, Sharma S, Sethuraman S, Ranga U, Krishnan UM. Stealth anti-CD4 conjugated immunoliposomes with dual antiretroviral drugs - Modern Trojan horses to combat HIV European Journal of Pharmaceutics and Biopharmaceutics. 89: 300-311. PMID 25500283 DOI: 10.1016/j.ejpb.2014.11.021  0.48
2014 Asokan M, Sachidanandam V, Satish KS, Ranga U. Attenuation of immune activation in an open-label clinical trial for HIV-AIDS using a polyherbal formulation. Virusdisease. 25: 302-13. PMID 25674597 DOI: 10.1007/s13337-014-0218-8  0.56
2014 Kashi VP, Jacob RA, Shamanna RA, Menon M, Balasiddaiah A, Varghese RK, Bachu M, Ranga U. The grafting of universal T-helper epitopes enhances immunogenicity of HIV-1 Tat concurrently improving its safety profile. Plos One. 9: e114155. PMID 25531437 DOI: 10.1371/journal.pone.0114155  0.48
2014 Pandeló José D, Bartholomeeusen K, da Cunha RD, Abreu CM, Glinski J, da Costa TB, Bacchi Rabay AF, Pianowski Filho LF, Dudycz LW, Ranga U, Peterlin BM, Pianowski LF, Tanuri A, Aguiar RS. Reactivation of latent HIV-1 by new semi-synthetic ingenol esters. Virology. 462: 328-39. PMID 25014309 DOI: 10.1016/j.virol.2014.05.033  0.52
2014 Boullosa J, Bachu M, Bila D, Ranga U, Süffert T, Sasazawa T, Tanuri A. Genetic diversity in HIV-1 subtype C LTR from Brazil and Mozambique generates new transcription factor-binding sites. Viruses. 6: 2495-504. PMID 24960272 DOI: 10.3390/v6062495  0.52
2014 Hanna LE, Neogi U, Ranga U, Swaminathan S, Prasad VR. Phylogenetic characterization of six full-length HIV-1 subtype C molecular clones from three patients: identification of rare subtype C strains containing two NF-κB motifs in the long terminal repeat. Aids Research and Human Retroviruses. 30: 586-91. PMID 24387762 DOI: 10.1089/AID.2013.0275  0.48
2014 Ramana LN, Sharma S, Sethuraman S, Ranga U, Krishnan UM. Evaluation of chitosan nanoformulations as potent anti-HIV therapeutic systems Biochimica Et Biophysica Acta - General Subjects. 1840: 476-484. PMID 24121104 DOI: 10.1016/j.bbagen.2013.10.002  0.48
2013 Nutan, Modi M, Dezzutti CS, Kulshreshtha S, Rawat AK, Srivastava SK, Malhotra S, Verma A, Ranga U, Gupta SK. Extracts from Acacia catechu suppress HIV-1 replication by inhibiting the activities of the viral protease and Tat. Virology Journal. 10: 309. PMID 25228267 DOI: 10.1186/1743-422X-10-309  0.48
2013 Asokan M, Lone IN, Mukthey AB, Siddhartha P, Mariappa G, Kotehal PK, Satish B, Wilson E, Sahayam S, Velayutham G, Perumal R, Baskaran K, Rengarajan D, Muthusamy R, Philip M, ... ... Ranga U, et al. Evident stabilization of the clinical profile in HIV/AIDS as evaluated in an open label clinical trial using a polyherbal formulation. The Indian Journal of Medical Research. 137: 1128-44. PMID 23852294  0.48
2013 Rao VR, Neogi U, Talboom JS, Padilla L, Rahman M, Fritz-French C, Gonzalez-Ramirez S, Verma A, Wood C, Ruprecht RM, Ranga U, Azim T, Joska J, Eugenin E, Shet A, et al. Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence. Retrovirology. 10: 61. PMID 23758766 DOI: 10.1186/1742-4690-10-61  0.48
2013 Mahadevan A, Ramalingaiah AH, Parthasarathy S, Nath A, Ranga U, Krishna SS. Neuropathological correlate of the "concentric target sign" in MRI of HIV-associated cerebral toxoplasmosis. Journal of Magnetic Resonance Imaging : Jmri. 38: 488-95. PMID 23440973 DOI: 10.1002/jmri.24036  0.48
2012 Bachu M, Yalla S, Asokan M, Verma A, Neogi U, Sharma S, Murali RV, Mukthey AB, Bhatt R, Chatterjee S, Rajan RE, Cheedarla N, Yadavalli VS, Mahadevan A, Shankar SK, ... ... Ranga U, et al. Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance. The Journal of Biological Chemistry. 287: 44714-35. PMID 23132857 DOI: 10.1074/jbc.M112.397158  0.48
2012 Ramana LN, Sharma S, Sethuraman S, Ranga U, Krishnan UM. Investigation on the stability of saquinavir loaded liposomes: Implication on stealth, release characteristics and cytotoxicity International Journal of Pharmaceutics. 431: 120-129. PMID 22569226 DOI: 10.1016/j.ijpharm.2012.04.054  0.48
2012 Bachu M, Mukthey AB, Murali RV, Cheedarla N, Mahadevan A, Shankar SK, Satish KS, Kundu TK, Ranga U. Sequence insertions in the HIV type 1 subtype C viral promoter predominantly generate an additional NF-κB binding site. Aids Research and Human Retroviruses. 28: 1362-8. PMID 22332607 DOI: 10.1089/aid.2011.0388  0.48
2012 Neogi U, Gupta S, Sahoo PN, Shet A, Rao SD, Ranga U, Prasad VR. Genetic characterization of HIV type 1 Tat exon 1 from a southern Indian clinical cohort: identification of unique epidemiological signature residues. Aids Research and Human Retroviruses. 28: 1152-6. PMID 22236201 DOI: 10.1089/AID.2011.0380  0.44
2011 Gadad SS, Rajan RE, Senapati P, Chatterjee S, Shandilya J, Dash PK, Ranga U, Kundu TK. HIV-1 infection induces acetylation of NPM1 that facilitates Tat localization and enhances viral transactivation. Journal of Molecular Biology. 410: 997-1007. PMID 21763502 DOI: 10.1016/j.jmb.2011.04.009  0.48
2011 Gadad SS, Senapati P, Syed SH, Rajan RE, Shandilya J, Swaminathan V, Chatterjee S, Colombo E, Dimitrov S, Pelicci PG, Ranga U, Kundu TK. The multifunctional protein nucleophosmin (NPM1) is a human linker histone H1 chaperone. Biochemistry. 50: 2780-9. PMID 21425800 DOI: 10.1021/bi101835j  0.48
2010 Liu Y, Nonnemacher MR, Stauff DL, Li L, Banerjee A, Irish B, Kilareski E, Rajagopalan N, Suchitra JB, Khan ZK, Ranga U, Wigdahl B. Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 64: 672-80. PMID 20970301 DOI: 10.1016/j.biopha.2010.09.007  0.48
2010 Ramana LN, Sethuraman S, Ranga U, Krishnan UM. Development of a liposomal nanodelivery system for nevirapine Journal of Biomedical Science. 17. PMID 20624325 DOI: 10.1186/1423-0127-17-57  0.48
2010 Madhavi Y, Puliyel JM, Mathew JL, Raghuram N, Phadke A, Shiva M, Srinivasan S, Paul Y, Srivastava RN, Parthasarathy A, Gupta S, Ranga U, Lakshmi VV, Joshi N, Nath I, et al. Evidence-based National Vaccine Policy. The Indian Journal of Medical Research. 131: 617-28. PMID 20516532  0.48
2010 Kumar GG, Mahadevan A, Guruprasad AS, Kovoor JM, Satishchandra P, Nath A, Ranga U, Shankar SK. Eccentric target sign in cerebral toxoplasmosis: neuropathological correlate to the imaging feature. Journal of Magnetic Resonance Imaging : Jmri. 31: 1469-72. PMID 20512900 DOI: 10.1002/jmri.22192  0.36
2010 Sreenath K, Pavithra L, Singh S, Sinha S, Dash PK, Siddappa NB, Ranga U, Mitra D, Chattopadhyay S. Nuclear matrix protein SMAR1 represses HIV-1 LTR mediated transcription through chromatin remodeling. Virology. 400: 76-85. PMID 20153010 DOI: 10.1016/j.virol.2010.01.017  0.48
2009 Kashi VP, Jacob RA, Paul S, Nayak K, Satish B, Swaminathan S, Satish KS, Ranga U. HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently. Vaccine. 27: 6739-47. PMID 19744585 DOI: 10.1016/j.vaccine.2009.08.078  0.56
2009 Gurjar SR, Mangaiarkarasi A, Ravi V, Ranga U, Desai A. Molecular characterization of a full-length genome of a HIV-2 isolate from India. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 329-35. PMID 19727000 DOI: 10.1097/QAI.0b013e3181b766be  0.36
2008 Rao VR, Sas AR, Eugenin EA, Siddappa NB, Bimonte-Nelson H, Berman JW, Ranga U, Tyor WR, Prasad VR. HIV-1 clade-specific differences in the induction of neuropathogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 10010-6. PMID 18829958 DOI: 10.1523/JNEUROSCI.2955-08.2008  0.48
2008 Dash PK, Siddappa NB, Mangaiarkarasi A, Mahendarkar AV, Roshan P, Anand KK, Mahadevan A, Satishchandra P, Shankar SK, Prasad VR, Ranga U. Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection. Retrovirology. 5: 25. PMID 18328091 DOI: 10.1186/1742-4690-5-25  0.44
2008 Mishra M, Vetrivel S, Siddappa NB, Ranga U, Seth P. Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif. Annals of Neurology. 63: 366-76. PMID 18074388 DOI: 10.1002/ana.21292  0.36
2007 Siddappa NB, Kashi VP, Venkatramanan M, Balasiddaiah A, Jayasuryan N, Mahadevan A, Desai A, Satish KS, Shankar SK, Ravi V, Ranga U. Gene expression analysis from human immunodeficiency virus type 1 subtype C promoter and construction of bicistronic reporter vectors. Aids Research and Human Retroviruses. 23: 1268-78. PMID 17961115 DOI: 10.1089/aid.2006.0305  0.56
2007 Mahadevan A, Shankar SK, Satishchandra P, Ranga U, Chickabasaviah YT, Santosh V, Vasanthapuram R, Pardo CA, Nath A, Zink MC. Characterization of human immunodeficiency virus (HIV)-infected cells in infiltrates associated with CNS opportunistic infections in patients with HIV clade C infection. Journal of Neuropathology and Experimental Neurology. 66: 799-808. PMID 17805010 DOI: 10.1097/NEN.0b013e3181461d3e  0.36
2007 Mantelingu K, Reddy BA, Swaminathan V, Kishore AH, Siddappa NB, Kumar GV, Nagashankar G, Natesh N, Roy S, Sadhale PP, Ranga U, Narayana C, Kundu TK. Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. Chemistry & Biology. 14: 645-57. PMID 17584612 DOI: 10.1016/j.chembiol.2007.04.011  0.4
2007 Siddappa NB, Avinash A, Venkatramanan M, Ranga U. Regeneration of commercial nucleic acid extraction columns without the risk of carryover contamination. Biotechniques. 42: 186, 188-92. PMID 17373483 DOI: 10.2144/000112327  0.36
2006 Siddappa NB, Venkatramanan M, Venkatesh P, Janki MV, Jayasuryan N, Desai A, Ravi V, Ranga U. Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein. Retrovirology. 3: 53. PMID 16916472 DOI: 10.1186/1742-4690-3-53  0.36
2006 Mahadevan A, Satishchandra P, Prachet KK, Sidappa NB, Ranga U, Santosh V, Yasha TC, Desai A, Ravi V, Shankar SK. Optic nerve axonal pathology is related to abnormal visual evoked responses in AIDS. Acta Neuropathologica. 112: 461-9. PMID 16788820 DOI: 10.1007/s00401-006-0089-1  0.36
2005 Siddappa NB, Dash PK, Mahadevan A, Desai A, Jayasuryan N, Ravi V, Satishchandra P, Shankar SK, Ranga U. Identification of unique B/C recombinant strains of HIV-1 in the southern state of Karnataka, India. Aids (London, England). 19: 1426-9. PMID 16103776  0.4
2004 Sinha S, Mathews T, Arunodaya GR, Siddappa NB, Ranga U, Desai A, Ravi V, Taly AB. HIV-1 clade-C-associated "ALS"-like disorder: first report from India. Journal of the Neurological Sciences. 224: 97-100. PMID 15450778 DOI: 10.1016/j.jns.2004.06.006  0.36
2004 Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, Kundu TK. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. The Journal of Biological Chemistry. 279: 51163-71. PMID 15383533 DOI: 10.1074/jbc.M409024200  0.4
2004 Ramakrishna L, Anand KK, Mahalingam M, Mohankumar KM, Ramani S, Siddappa NB, Ranga U. Codon optimization and ubiquitin conjugation of human immunodeficiency virus-1 Tat lead to enhanced cell-mediated immune responses. Vaccine. 22: 2586-98. PMID 15193384 DOI: 10.1016/j.vaccine.2003.12.007  0.36
2004 Siddappa NB, Dash PK, Mahadevan A, Jayasuryan N, Hu F, Dice B, Keefe R, Satish KS, Satish B, Sreekanthan K, Chatterjee R, Venu K, Satishchandra P, Ravi V, Shankar SK, ... ... Ranga U, et al. Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India. Journal of Clinical Microbiology. 42: 2742-51. PMID 15184461 DOI: 10.1128/JCM.42.6.2742-2751.2004  0.56
2004 Ranga U, Shankarappa R, Siddappa NB, Ramakrishna L, Nagendran R, Mahalingam M, Mahadevan A, Jayasuryan N, Satishchandra P, Shankar SK, Prasad VR. Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. Journal of Virology. 78: 2586-90. PMID 14963162  0.44
2003 Satya RV, Mukherjee A, Ranga U. A pattern matching algorithm for codon optimization and CpG motif-engineering in DNA expression vectors. Proceedings / Ieee Computer Society Bioinformatics Conference. Ieee Computer Society Bioinformatics Conference. 2: 294-305. PMID 16452805 DOI: 10.1109/CSB.2003.1227330  0.48
Show low-probability matches.